Literature DB >> 25569542

Biting back: vaccine efforts redoubled as rabies deadline looms.

Shraddha Chakradhar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25569542     DOI： 10.1038/nm0115-8

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  5 in total

1.  Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: a randomized, dose-escalation phase 1 study in adults.

Authors:  Nithya Gogtay; Urmila Thatte; Nilima Kshirsagar; Brett Leav; Deborah Molrine; Peter Cheslock; Subhash V Kapre; Prasad S Kulkarni
Journal:  Vaccine       Date:  2012-09-23       Impact factor: 3.641

2.  First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity.

Authors:  A B H Bakker; C Python; C J Kissling; P Pandya; W E Marissen; M F Brink; F Lagerwerf; S Worst; E van Corven; S Kostense; K Hartmann; G J Weverling; F Uytdehaag; C Herzog; D J Briggs; C E Rupprecht; R Grimaldi; J Goudsmit
Journal:  Vaccine       Date:  2008-09-17       Impact factor: 3.641

3.  Postexposure rabies prophylaxis completed in 1 week: preliminary study.

Authors:  Prapimporn Shantavasinkul; Thanphet Tantawichien; Henry Wilde; Artikaya Sawangvaree; Apinya Kumchat; Natthasri Ruksaket; Vitool Lohsoonthorn; Pakamatz Khawplod; Terapong Tantawichien
Journal:  Clin Infect Dis       Date:  2010-01-01       Impact factor: 9.079

4.  Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India.

Authors:  Mysore Kalappa Sudarshan; Doddabele Hanumanthaiah Ashwath Narayana; Shampur Narayan Madhusudana; Ramesh Holla; Belludi Yajaman Ashwin; Bilagumba Gangaboraiah; Haradanahalli S Ravish
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

5.  Human rabies case with long incubation, Australia.

Authors:  Nicholas Johnson; Anthony Fooks; Kenneth McColl
Journal:  Emerg Infect Dis       Date:  2008-12       Impact factor: 6.883
  5 in total
  2 in total

Review 1.  Current Developments and Future Prospects for Plant-Made Biopharmaceuticals Against Rabies.

Authors:  Sergio Rosales-Mendoza
Journal:  Mol Biotechnol       Date:  2015-10       Impact factor: 2.695

2.  Safety comparison of four types of rabies vaccines in patients with WHO category II animal exposure: An observation based on different age groups.

Authors:  Jun Peng; Sha Lu; Zhenggang Zhu; Man Zhang; Quan Hu; Yuan Fang
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.